Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature
Knoll L, Kraemer I, Thiesen J. (Laura.knoll@unimedizin-mainz.de)
EJHP - 2023 - ; 30, 1: 11-16.

Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
Almasi J, Erdnuss F, Thiesen J, Krämer I. (jannick.almasi@unimedizin-mainz.fr)
Pharmaceutical Technology in Hospital Pharmacy - 2023 - ;8,1

Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags.
Linxweiler H, Thiesen J, Krämer I. (helen.linxweiler@unimedizin-mainz.de)
EAHP Congress Vienna - 2022 -

In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion.
Mohr A, Krämer I. ()
EJHP - 2020 -

Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln.
Krämer I, Sarakbi I, Thiesen J, Mainz. (KPH-AboService@Deutscher-Apotheker-Verlag.de)
Krankenhauspharmazie - 2017 - ;38,7:334?340.

Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period.
Kim S.H, Krämer I. (sunnyahza@naver.com)
J Oncol Pharm Practice - 2017 - ;25,2: 339-350

Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions.
Spindeldreier K, Thiesen J, Lipp H.P, Krämer I. (irene.kraemer@unimedizin-mainz.de)
J Oncol Pharm Practice - 2014 - ; 20: 183-189

Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate.
Krämer I, Walz-Jung H, Stanko C, Kamin W. (irene.kraemer@unimedizin-mainz.de)
EJHP - 2013 - ;20:36-41

Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
Wollstadt A, Krämer I, Kamin W. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 2013 - ; 68: 744-748.

Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml.
Gilcher Th, Heeb R M, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Krankenhauspharmazie - 2013 - ; 11: 524-525.

Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags.
Kaiser J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
EJHP Science - 2011 - ; 17, 1: 7-12.

Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags.
Kaiser J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Int J Pharm Compound - 2011 - ; 15, 6 : 515-520.

Physikalisch-chemische Stabilität von Clofarabin-Zubereitungen.
Kaiser J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Poster ADKA Congress May 2010 - 2010 -

Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Krämer I, Schwabe A, Lichtinghagen R, Kamin W. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 2007 - ; 62, 10: 760-766.

Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krämer I, Schwabe A, Kamin W. (irene.kraemer@unimedizin-mainz.de)
Krankenhauspharmazie - 2007 - ; 28, 5: 170-178.

Characterization of an extemporaneous liquid formulation of lisinopril
Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL. ()
Am J Health-Syst Pharm - 2003 - ; 60: 69-74.

Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Thiesen J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Pharm World Sci - 1999 - ; 21: 137-141.

Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
Sattler A, Jage J, Krämer I. (irene.kraemer@unimedizin-mainz.de)
Pharmazie - 1998 - ; 53: 386-391.

Pharmazeutische aspekte von topotecan-infusionen.
Krämer I, Thiesen J. (irene.kraemer@unimedizin-mainz.de)
TAP Pharmazeutische Zeitung - 1997 - ; 31: 30-33.